Stay updated on SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial

Sign up to get notified when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing v3.5.3, representing a minor version update.
    Difference
    0.0%
    Check dated 2026-05-17T09:29:27.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    ClinicalTrials.gov updated the study record revision/date and refined the treatment regimen details (e.g., calaspargase pegol administration description) and monitoring language for trial procedures. It also updated key eligibility/evaluability and primary/expansion outcome descriptions, including the DLT evaluability thresholds for dose-finding and how MRD-negative remission is described for patients under 6 months.
    Difference
    0.9%
    Check dated 2026-04-25T05:27:47.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    - Page revision updated to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T03:50:21.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added MRD-negative remission rate endpoints for infants and older infants, and expanded exploratory objectives to include PK analyses of calaspargase pegol within the revumenib-plus-chemotherapy regimen. Updated regimen descriptions and cycle structure, and removed certain MRD and PK items from the previous version.
    Difference
    0.8%
    Check dated 2026-04-03T18:37:14.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page. The change appears to be a global versioning update with no visible edits to study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-03-20T04:56:37.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-05T19:00:43.000Z thumbnail image

Stay in the know with updates to SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.